S. R. Shyam Sundar
#111,028
Most Influential Person Now
S. R. Shyam Sundar's AcademicInfluence.com Rankings
S. R. Shyam Sundarcommunications Degrees
Communications
#4132
World Rank
#5779
Historical Rank
Linguistics
#745
World Rank
#967
Historical Rank
Download Badge
Communications
S. R. Shyam Sundar's Degrees
- PhD Communication Stanford University
- Masters Communication Stanford University
- Bachelors Communication Stanford University
Why Is S. R. Shyam Sundar Influential?
(Suggest an Edit or Addition)S. R. Shyam Sundar's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? (2007) (1512)
- Drug Resistance in Leishmaniasis (2006) (914)
- Drug Resistance in Leishmaniasis (2010) (801)
- Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. (2002) (785)
- Oral miltefosine for Indian visceral leishmaniasis. (2002) (730)
- Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic. (2000) (637)
- Drug resistance in Indian visceral leishmaniasis (2001) (587)
- Laboratory Diagnosis of Visceral Leishmaniasis (2002) (548)
- Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis. (1999) (463)
- Injectable paromomycin for Visceral leishmaniasis in India. (2007) (414)
- Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance. (2011) (388)
- Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani. (1999) (382)
- Single-dose liposomal amphotericin B for visceral leishmaniasis in India. (2010) (365)
- Antimony Toxicity (2010) (363)
- Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis (2007) (338)
- Leishmaniasis: new approaches to disease control (2003) (338)
- Liposomal amphotericin B for the treatment of visceral leishmaniasis. (2006) (319)
- Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial (2011) (308)
- Rapid accurate field diagnosis of Indian visceral leishmaniasis (1998) (281)
- Drug Uptake and Modulation of Drug Resistance in Leishmania by an Aquaglyceroporin* (2004) (264)
- Efficacy of miltefosine in the treatment of visceral leishmaniasis in India after a decade of use. (2012) (253)
- Diagnosis of visceral leishmaniasis. (2011) (242)
- Phase 4 trial of miltefosine for the treatment of Indian visceral leishmaniasis. (2007) (242)
- Visceral leishmaniasis - current therapeutic modalities. (2006) (238)
- Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980-2004. (2005) (233)
- Trial of oral miltefosine for visceral leishmaniasis (1998) (232)
- Leishmaniasis: an update of current pharmacotherapy (2013) (229)
- An update on pharmacotherapy for leishmaniasis (2015) (222)
- Molecular mechanisms of antimony resistance in Leishmania. (2007) (208)
- Mechanisms of experimental resistance of Leishmania to miltefosine: Implications for clinical use. (2006) (201)
- New treatment approach in Indian visceral leishmaniasis: single-dose liposomal amphotericin B followed by short-course oral miltefosine. (2008) (193)
- Diagnostic tests for kala-azar: a multi-centre study of the freeze-dried DAT, rK39 strip test and KAtex in East Africa and the Indian subcontinent. (2008) (193)
- Amphotericin B treatment for Indian visceral leishmaniasis: conventional versus lipid formulations. (2004) (186)
- Miltefosine in the treatment of leishmaniasis: Clinical evidence for informed clinical risk management (2007) (185)
- Treatment of Indian visceral leishmaniasis with single or daily infusions of low dose liposomal amphotericin B: randomised trial. (2001) (178)
- The poorest of the poor: a poverty appraisal of households affected by visceral leishmaniasis in Bihar, India (2009) (174)
- A Proteomics Screen Implicates HSP83 and a Small Kinetoplastid Calpain-related Protein in Drug Resistance in Leishmania donovani Clinical Field Isolates by Modulating Drug-induced Programmed Cell Death* (2007) (172)
- Visceral Leishmaniasis in the Indian Subcontinent: Modelling Epidemiology and Control (2011) (163)
- Serial Quantitative PCR Assay for Detection, Species Discrimination, and Quantification of Leishmania spp. in Human Samples (2011) (159)
- IL-10 neutralization promotes parasite clearance in splenic aspirate cells from patients with visceral leishmaniasis. (2011) (155)
- Asymptomatic Leishmania infection: a new challenge for Leishmania control. (2014) (153)
- Advances in the treatment of leishmaniasis (2002) (152)
- Efficacy and tolerability of miltefosine for childhood visceral leishmaniasis in India. (2004) (151)
- Splenic cytokine responses in Indian kala-azar before and after treatment. (1998) (148)
- Short-course of oral miltefosine for treatment of visceral leishmaniasis. (2000) (148)
- Circulating T helper 1 (Th1) cell- and Th2 cell-associated cytokines in Indian patients with visceral leishmaniasis. (1997) (146)
- Incidence of Symptomatic and Asymptomatic Leishmania donovani Infections in High-Endemic Foci in India and Nepal: A Prospective Study (2011) (145)
- IL-27 and IL-21 Are Associated with T Cell IL-10 Responses in Human Visceral Leishmaniasis (2011) (143)
- A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine for use in the prevention of visceral leishmaniasis. (2011) (141)
- A Global Comparative Evaluation of Commercial Immunochromatographic Rapid Diagnostic Tests for Visceral Leishmaniasis (2012) (139)
- Serious underreporting of visceral leishmaniasis through passive case reporting in Bihar, India (2006) (139)
- Targeted killing of Leishmania donovani in vivo and in vitro with amphotericin B attached to functionalized carbon nanotubes. (2011) (135)
- Visceral Leishmaniasis Elimination Programme in India, Bangladesh, and Nepal: Reshaping the Case Finding/Case Management Strategy (2009) (132)
- Current challenges in treatment options for visceral leishmaniasis in India: a public health perspective (2016) (132)
- Single-dose liposomal amphotericin B in the treatment of visceral leishmaniasis in India: a multicenter study. (2003) (131)
- Liposomal Amphotericin B and Leishmaniasis: Dose and Response (2010) (129)
- Availability of miltefosine for the treatment of kala-azar in India. (2005) (127)
- Evolutionary genomics of epidemic visceral leishmaniasis in the Indian subcontinent (2016) (126)
- Visceral leishmaniasis (kala-azar): challenges ahead. (2006) (125)
- Refractoriness to the treatment of sodium stibogluconate in Indian kala-azar field isolates persist in in vitro and in vivo experimental models (2005) (122)
- Characterization of natural antimony resistance in Leishmania donovani isolates. (2007) (120)
- Visceral leishmaniasis: elimination with existing interventions. (2011) (114)
- Immunochromatographic strip-test detection of anti-K39 antibody in Indian visceral leishmaniasis (2002) (113)
- Oral miltefosine for the treatment of Indian visceral leishmaniasis. (2006) (112)
- Cost-Effectiveness Analysis of Combination Therapies for Visceral Leishmaniasis in the Indian Subcontinent (2010) (111)
- Evaluation of rapid diagnostic tests: visceral leishmaniasis (2007) (109)
- CD8 T cell exhaustion in human visceral leishmaniasis. (2013) (108)
- Oral treatment of visceral leishmaniasis with miltefosine. (1999) (107)
- A cluster of cases of severe cardiotoxicity among kala-azar patients treated with a high-osmolarity lot of sodium antimony gluconate. (1998) (107)
- Case study for a vaccine against leishmaniasis. (2013) (107)
- Enzyme-Linked Immunosorbent Assay for Recombinant K39 Antigen in Diagnosis and Prognosis of Indian Visceral Leishmaniasis (2001) (107)
- Increased levels of thiols protect antimony unresponsive Leishmania donovani field isolates against reactive oxygen species generated by trivalent antimony (2007) (106)
- Genetics and visceral leishmaniasis: of mice and man (2009) (105)
- Longlasting insecticidal nets for prevention of Leishmania donovani infection in India and Nepal: paired cluster randomised trial (2010) (102)
- Response to interferon-γ plus pentavalent antimony in Indian visceral leishmaniasis (1997) (102)
- Low-dose liposomal amphotericin B in refractory Indian visceral leishmaniasis: a multicenter study. (2002) (100)
- Recent developments and future prospects in the treatment of visceral leishmaniasis (2016) (100)
- Drug Susceptibility in Leishmania Isolates Following Miltefosine Treatment in Cases of Visceral Leishmaniasis and Post Kala-Azar Dermal Leishmaniasis (2012) (100)
- Reassessment of Immune Correlates in Human Visceral Leishmaniasis as Defined by Cytokine Release in Whole Blood (2012) (100)
- Short-Course, Low-Dose Amphotericin B Lipid Complex Therapy for Visceral Leishmaniasis Unresponsive to Antimony (1997) (98)
- Common variants in the HLA-DRB1-HLA-DQA1 Class II region are associated with susceptibility to visceral leishmaniasis (2013) (97)
- Elimination of visceral leishmaniasis on the Indian subcontinent. (2016) (94)
- Inhibition of ABC Transporters Abolishes Antimony Resistance in Leishmania Infection (2007) (93)
- Rapid, Noninvasive Diagnosis of Visceral Leishmaniasis in India: Comparison of Two Immunochromatographic Strip Tests for Detection of Anti-K39 Antibody (2006) (93)
- Serological diagnosis of Indian visceral leishmaniasis: direct agglutination test versus rK39 strip test. (2006) (91)
- Use of Leishmania donovani Field Isolates Expressing the Luciferase Reporter Gene in In Vitro Drug Screening (2005) (90)
- Multilocus microsatellite typing (MLMT) reveals genetic homogeneity of Leishmania donovani strains in the Indian subcontinent. (2009) (89)
- Evaluation of PCR for Diagnosis of Indian Kala-Azar and Assessment of Cure (2005) (89)
- Leishmaniasis: vaccine candidates and perspectives. (2012) (86)
- Oral miltefosine treatment in children with mild to moderate Indian visceral leishmaniasis (2003) (86)
- Vector control by insecticide‐treated nets in the fight against visceral leishmaniasis in the Indian subcontinent, what is the evidence? (2008) (86)
- Antibody response against a Leishmania donovani amastigote-stage-specific protein in patients with visceral leishmaniasis (1997) (86)
- Implementation research to support the initiative on the elimination of kala azar from Bangladesh, India and Nepal – the challenges for diagnosis and treatment (2008) (84)
- Immunochemotherapy for a systemic intracellular infection: accelerated response using interferon-gamma in visceral leishmaniasis. (1995) (84)
- Clinicoepidemiological study of drug resistance in Indian kala - azar (1994) (84)
- Characterisation of antimony-resistant Leishmania donovani isolates: biochemical and biophysical studies and interaction with host cells. (2011) (84)
- Blimp-1-Dependent IL-10 Production by Tr1 Cells Regulates TNF-Mediated Tissue Pathology (2016) (83)
- Detection of leishmanial antigen in the urine of patients with visceral leishmaniasis by a latex agglutination test. (2005) (83)
- Amphotericin B treatment for Indian visceral leishmaniasis: response to 15 daily versus alternate-day infusions. (2007) (83)
- Antimony-resistant but not antimony-sensitive Leishmania donovani up-regulates host IL-10 to overexpress multidrug-resistant protein 1 (2013) (81)
- High incidence of zidovudine induced anaemia in HIV infected patients in eastern India. (2010) (81)
- Current and emerging medications for the treatment of leishmaniasis (2019) (81)
- An oral formulation of amphotericin B attached to functionalized carbon nanotubes is an effective treatment for experimental visceral leishmaniasis. (2012) (80)
- Diagnosis of Indian Visceral Leishmaniasis by Nucleic Acid Detection Using PCR (2011) (79)
- Correlation between CD4 counts of HIV patients and enteric protozoan in different seasons – An experience of a tertiary care hospital in Varanasi (India) (2008) (78)
- Successful Treatment Of Refractory Visceral Leishmaniasis In India Using Antimony Plus Interferon-ã (1994) (78)
- A phase II dose-ranging study of sitamaquine for the treatment of visceral leishmaniasis in India. (2005) (77)
- Antileishmanial activity of nano-amphotericin B deoxycholate. (2008) (77)
- Eliminating visceral leishmaniasis in South Asia: the road ahead (2019) (76)
- Comparative evaluation of parasitology and serological tests in the diagnosis of visceral leishmaniasis in India: a phase III diagnostic accuracy study (2006) (76)
- Study on clinico-epidemiological profile of HIV patients in eastern India. (2006) (75)
- Elevated levels of tryparedoxin peroxidase in antimony unresponsive Leishmania donovani field isolates. (2010) (74)
- Chemotherapeutics of visceral leishmaniasis: present and future developments (2017) (73)
- Developments in Diagnosis of Visceral Leishmaniasis in the Elimination Era (2015) (73)
- Evaluation of rK28 antigen for serodiagnosis of visceral Leishmaniasis in India. (2012) (72)
- Effect of Village-wide Use of Long-Lasting Insecticidal Nets on Visceral Leishmaniasis Vectors in India and Nepal: A Cluster Randomized Trial (2010) (72)
- Resistance to treatment in Kala-azar: speciation of isolates from northeast India. (2001) (71)
- Study of parasite kinetics with antileishmanial drugs using real-time quantitative PCR in Indian visceral leishmaniasis. (2011) (71)
- Mapping the Antigenicity of the Parasites in Leishmania donovani Infection by Proteome Serology (2006) (69)
- Molecular Diagnosis of Visceral Leishmaniasis (2018) (69)
- Strong Association between Serological Status and Probability of Progression to Clinical Visceral Leishmaniasis in Prospective Cohort Studies in India and Nepal (2014) (69)
- Virgin soil: the spread of visceral leishmaniasis into Uttar Pradesh, India. (2005) (69)
- The NK cell granule protein NKG7 regulates cytotoxic granule exocytosis and inflammation (2020) (69)
- Measurement of Recent Exposure to Phlebotomus argentipes, the Vector of Indian Visceral Leishmaniasis, by Using Human Antibody Responses to Sand Fly Saliva (2010) (68)
- Nano-structured nickel oxide based DNA biosensor for detection of visceral leishmaniasis (Kala-azar). (2011) (67)
- Persistence of Leishmania donovani Antibodies in Past Visceral Leishmaniasis Cases in India (2010) (66)
- Noninvasive management of Indian visceral leishmaniasis: clinical application of diagnosis by K39 antigen strip testing at a kala-azar referral unit. (2002) (66)
- Knowledge, attitude, and practices related to Kala-azar in a rural area of Bihar state, India. (2006) (65)
- Diarrhea, CD4 counts and enteric infections in a hospital – based cohort of HIV-infected patients around Varanasi, India (2006) (64)
- Intracellular survival of Leishmania species that cause visceral leishmaniasis is significantly reduced by HIV-1 protease inhibitors. (2008) (63)
- Cytokine Responses to Novel Antigens in an Indian Population Living in an Area Endemic for Visceral Leishmaniasis (2012) (63)
- Elongation Factor-2, a Th1 Stimulatory Protein of Leishmania donovani, Generates Strong IFN-γ and IL-12 Response in Cured Leishmania-Infected Patients/Hamsters and Protects Hamsters against Leishmania Challenge (2011) (62)
- Differential Expression of miRNA Regulates T Cell Differentiation and Plasticity During Visceral Leishmaniasis Infection (2016) (62)
- Compararative evaluation of rK9, rK26 and rK39 antigens in the serodiagnosis of Indian visceral leishmaniasis. (2010) (62)
- Cure of antimony-unresponsive Indian visceral leishmaniasis with amphotericin B lipid complex. (1996) (61)
- Novel mechanism of drug resistance in kala azar field isolates. (2003) (60)
- The In Vivo Susceptibility of Leishmania donovani to Sodium Stibogluconate Is Drug Specific and Can Be Reversed by Inhibiting Glutathione Biosynthesis (2003) (59)
- A multiattribute utility evaluation of different methods for the detection of enteric protozoa causing diarrhea in AIDS patients (2010) (59)
- Increased miltefosine tolerance in clinical isolates of Leishmania donovani is associated with reduced drug accumulation, increased infectivity and resistance to oxidative stress (2017) (59)
- Evaluation of the direct agglutination test as an immunodiagnostic tool for kala-azar in India. (1993) (59)
- Efficacy and safety of single-dose liposomal amphotericin B for visceral leishmaniasis in a rural public hospital in Bangladesh: a feasibility study. (2014) (59)
- Failure of Miltefosine Treatment for Visceral Leishmaniasis in Children and Men in South-East Asia (2014) (59)
- Immunotherapy and Targeted Therapies in Treatment of Visceral Leishmaniasis: Current Status and Future Prospects (2014) (58)
- Immunostimulatory cellular responses of cured Leishmania‐infected patients and hamsters against the integral membrane proteins and non‐membranous soluble proteins of a recent clinical isolate of Leishmania donovani (2005) (58)
- Serological Markers of Sand Fly Exposure to Evaluate Insecticidal Nets against Visceral Leishmaniasis in India and Nepal: A Cluster-Randomized Trial (2011) (57)
- Proteome mapping of overexpressed membrane-enriched and cytosolic proteins in sodium antimony gluconate (SAG) resistant clinical isolate of Leishmania donovani. (2010) (57)
- Understanding the transmission dynamics of Leishmania donovani to provide robust evidence for interventions to eliminate visceral leishmaniasis in Bihar, India (2016) (57)
- Elucidation of Cellular Mechanisms Involved in Experimental Paromomycin Resistance in Leishmania donovani (2014) (57)
- Cost‐effectiveness projections of single and combination therapies for visceral leishmaniasis in Bihar, India (2009) (57)
- Heterogeneity of Leishmania donovani Parasites Complicates Diagnosis of Visceral Leishmaniasis: Comparison of Different Serological Tests in Three Endemic Regions (2015) (56)
- NADH-oxidase, NADPH-oxidase and myeloperoxidase activity of visceral leishmaniasis patients. (2002) (56)
- Leishmania Specific CD4 T Cells Release IFNγ That Limits Parasite Replication in Patients with Visceral Leishmaniasis (2014) (56)
- Photo-induced rapid biosynthesis of silver nanoparticle using aqueous extract of Xanthium strumarium and its antibacterial and antileishmanial activity (2016) (56)
- Detection of Leptomonas sp. parasites in clinical isolates of Kala-azar patients from India. (2010) (56)
- Who is a typical patient with visceral leishmaniasis? Characterizing the demographic and nutritional profile of patients in Brazil, East Africa, and South Asia. (2011) (55)
- Latent Infection with Leishmania donovani in Highly Endemic Villages in Bihar, India (2013) (55)
- Treatment of antimony-unresponsive Indian visceral leishmaniasis with ultra-short courses of amphotericin-B-lipid complex. (1998) (54)
- Genome-wide SNP and microsatellite variation illuminate population-level epidemiology in the Leishmania donovani species complex (2012) (54)
- Unusual Case of Resistance to Amphotericin B in Visceral Leishmaniasis in a Region in India Where Leishmaniasis Is Not Endemic (2011) (54)
- Costs of patient management of visceral leishmaniasis in Muzaffarpur, Bihar, India (2006) (54)
- The epidemiology of Leishmania donovani infection in high transmission foci in India (2010) (53)
- Differential gene expression analysis in antimony-unresponsive Indian kala azar (visceral leishmaniasis) clinical isolates by DNA microarray (2007) (52)
- Visceral Leishmaniasis and Arsenic: An Ancient Poison Contributing to Antimonial Treatment Failure in the Indian Subcontinent? (2011) (51)
- Miltefosine‐unresponsive Leishmania donovani has a greater ability than miltefosine‐responsive L. donovani to resist reactive oxygen species (2013) (51)
- Increased metacyclogenesis of antimony-resistant Leishmania donovani clinical lines (2011) (50)
- Risk Factors for Visceral Leishmaniasis and Asymptomatic Leishmania donovani Infection in India and Nepal (2014) (50)
- Anatomical Variations of Cystic Ducts in Magnetic Resonance Cholangiopancreatography and Clinical Implications (2016) (50)
- Treatment of Visceral Leishmaniasis: Model-Based Analyses on the Spread of Antimony-Resistant L. donovani in Bihar, India (2012) (49)
- Visceral Leishmaniasis in Muzaffarpur District, Bihar, India from 1990 to 2008 (2011) (49)
- Response to interferon-gamma plus pentavalent antimony in Indian visceral leishmaniasis. (1997) (49)
- Risk factors for visceral leishmaniasis in India: further evidence on the role of domestic animals (2010) (49)
- Effect of Treatment with Interferon-γ Alone in Visceral Leishmaniasis (1995) (49)
- Visceral Leishmaniasis in Rural Bihar, India (2012) (49)
- Paromomycin in the treatment of leishmaniasis (2008) (49)
- Imipramine Is an Orally Active Drug against Both Antimony Sensitive and Resistant Leishmania donovani Clinical Isolates in Experimental Infection (2012) (49)
- Interferon-Gamma Release Assay (Modified QuantiFERON) as a Potential Marker of Infection for Leishmania donovani, a Proof of Concept Study (2011) (48)
- Longitudinal seroepidemiologic study of visceral leishmaniasis in hyperendemic regions of Bihar, India. (2009) (48)
- Identifying vaccine targets for anti-leishmanial vaccine development (2014) (48)
- Strategies to Overcome Antileishmanial Drugs Unresponsiveness (2014) (48)
- Mannose-conjugated curcumin-chitosan nanoparticles: Efficacy and toxicity assessments against Leishmania donovani. (2018) (48)
- Validation of a simple resazurin-based promastigote assay for the routine monitoring of miltefosine susceptibility in clinical isolates of Leishmania donovani (2013) (47)
- Phase 4 Pharmacovigilance Trial of Paromomycin Injection for the Treatment of Visceral Leishmaniasis in India (2011) (47)
- Comparative evaluation of freeze‐dried and liquid antigens in the direct agglutination test for serodiagnosis of visceral leishmaniasis (ITMA‐DAT/VL) (2006) (47)
- Evaluation of Blood Agar Microtiter Plates for Culturing Leishmania Parasites To Titrate Parasite Burden in Spleen and Peripheral Blood of Patients with Visceral Leishmaniasis (2010) (47)
- Leishmania donovani: identification of stimulatory soluble antigenic proteins using cured human and hamster lymphocytes for their prophylactic potential against visceral leishmaniasis. (2006) (47)
- Treatment of visceral leishmaniasis (2001) (47)
- Drug targeting to infectious diseases by nanoparticles surface functionalized with special biomolecules. (2012) (47)
- Flow cytometric determination of intracellular non-protein thiols in Leishmania promastigotes using 5-chloromethyl fluorescein diacetate. (2009) (46)
- Febrifugine analogues as Leishmania donovani trypanothione reductase inhibitors: binding energy analysis assisted by molecular docking, ADMET and molecular dynamics simulation (2017) (46)
- An in vitro study of apoptotic like death in Leishmania donovani promastigotes by withanolides. (2013) (46)
- Transgenic Leishmania donovani clinical isolates expressing green fluorescent protein constitutively for rapid and reliable ex vivo drug screening. (2009) (46)
- Molecular Docking and in Vitro Antileishmanial Evaluation of Chromene-2-thione Analogues. (2012) (46)
- Investigational drugs for visceral leishmaniasis (2015) (45)
- Model-Based Investigations of Different Vector-Related Intervention Strategies to Eliminate Visceral Leishmaniasis on the Indian Subcontinent (2014) (45)
- Correlation between clinical features and degree of immunosuppression in HIV infected children. (2008) (45)
- Short-course, cost-effective treatment with amphotericin B-fat emulsion cures visceral leishmaniasis. (2000) (45)
- Variable degree of alternative complement pathway-mediated hemolysis in Indian visceral leishmaniasis induced by differential expression of 9-O-acetylated sialoglycans. (2004) (44)
- Evaluation of leishmanin skin test in Indian visceral leishmaniasis. (2009) (44)
- Quantitative PCR in Epidemiology for Early Detection of Visceral Leishmaniasis Cases in India (2014) (44)
- Hematological profile of HIV patients in relation to immune status - a hospital-based cohort from Varanasi, North India. (2008) (43)
- Evaluation of Leishmania donovani Protein Disulfide Isomerase as a Potential Immunogenic Protein/Vaccine Candidate against Visceral Leishmaniasis (2012) (43)
- Seasonal Variation in the Prevalence of Sand Flies Infected with Leishmania donovani (2013) (43)
- Experimental Induction of Paromomycin Resistance in Antimony-Resistant Strains of L. donovani: Outcome Dependent on In Vitro Selection Protocol (2012) (43)
- Short-course paromomycin treatment of visceral leishmaniasis in India: 14-day vs 21-day treatment. (2009) (43)
- Paromomycin in the treatment of leishmaniasis. (2008) (43)
- Oral miltefosine for Indian post‐kala‐azar dermal leishmaniasis: a randomised trial (2013) (43)
- In vitro susceptibility of Leishmania donovani to miltefosine in Indian visceral leishmaniasis. (2013) (42)
- Emerging therapeutic targets for treatment of leishmaniasis (2018) (42)
- IgG1 as a Potential Biomarker of Post-chemotherapeutic Relapse in Visceral Leishmaniasis, and Adaptation to a Rapid Diagnostic Test (2014) (42)
- Developing imidazole analogues as potential inhibitor for Leishmania donovani trypanothione reductase: virtual screening, molecular docking, dynamics and ADMET approach (2015) (41)
- Anthropometrically derived dosing and drug costing calculations for treating visceral leishmaniasis in Bihar, India (2009) (41)
- Structure-based virtual screening, molecular docking, ADMET and molecular simulations to develop benzoxaborole analogs as potential inhibitor against Leishmania donovani trypanothione reductase (2017) (40)
- Modified solid lipid nanoparticles encapsulated with Amphotericin B and Paromomycin: an effective oral combination against experimental murine visceral leishmaniasis (2020) (40)
- Characterization of Glycolytic Enzymes - rAldolase and rEnolase of Leishmania donovani, Identified as Th1 Stimulatory Proteins, for Their Immunogenicity and Immunoprophylactic Efficacies against Experimental Visceral Leishmaniasis (2014) (40)
- Visceral leishmaniasis elimination targets in India, strategies for preventing resurgence (2018) (40)
- A simple and sensitive test for field diagnosis of post kala‐azar dermal leishmaniasis (2001) (39)
- Options for Active Case Detection of Visceral Leishmaniasis in Endemic Districts of India, Nepal and Bangladesh, Comparing Yield, Feasibility and Costs (2011) (39)
- Single-dose indigenous liposomal amphotericin B in the treatment of Indian visceral leishmaniasis: a phase 2 study. (2015) (39)
- Efficacy and Safety of Amphotericin B Emulsion versus Liposomal Formulation in Indian Patients with Visceral Leishmaniasis: A Randomized, Open-Label Study (2014) (39)
- Role of Efflux Pumps and Intracellular Thiols in Natural Antimony Resistant Isolates of Leishmania donovani (2013) (39)
- Management of visceral leishmaniasis in rural primary health care services in Bihar, India (2010) (39)
- Ambisome plus miltefosine for Indian patients with kala-azar. (2011) (39)
- Arsenic Exposure and Outcomes of Antimonial Treatment in Visceral Leishmaniasis Patients in Bihar, India: A Retrospective Cohort Study (2015) (39)
- Outcome of patients on second line antiretroviral therapy under programmatic condition in India (2015) (38)
- Visceral Leishmaniasis Rapid Diagnostic Test Performance (2011) (38)
- SOLiD™ Sequencing of Genomes of Clinical Isolates of Leishmania donovani from India Confirm Leptomonas Co-Infection and Raise Some Key Questions (2013) (38)
- Leishmania specific CD4 T cells release IFN-γ that limits parasite replication in patients with visceral leishmaniasis (2014) (38)
- Molecular and serological markers of Leishmania donovani infection in healthy individuals from endemic areas of Bihar, India (2013) (38)
- Heterologous priming-boosting with DNA and vaccinia virus expressing kinetoplastid membrane protein-11 induces potent cellular immune response and confers protection against infection with antimony resistant and sensitive strains of Leishmania (Leishmania) donovani. (2013) (38)
- Parasite load estimation by qPCR differentiates between asymptomatic and symptomatic infection in Indian visceral leishmaniasis. (2014) (38)
- Molecular docking, structure-activity relationship and biological evaluation of the anticancer drug monastrol as a pteridine reductase inhibitor in a clinical isolate of Leishmania donovani. (2010) (37)
- Common and Uncommon Anatomical Variants of Intrahepatic Bile Ducts in Magnetic Resonance Cholangiopancreatography and its Clinical Implication (2016) (37)
- Downregulation of Mitogen-Activated Protein Kinase 1 of Leishmania donovani Field Isolates Is Associated with Antimony Resistance (2011) (36)
- Xenodiagnosis to evaluate the infectiousness of humans to sandflies in an area endemic for visceral leishmaniasis in Bihar, India: a transmission-dynamics study (2021) (35)
- Treatment of kala-azar with oral fluconazole (1996) (34)
- Evaluation of ex vivo human immune response against candidate antigens for a visceral leishmaniasis vaccine. (2010) (34)
- Classification and Regression Tree and Spatial Analyses Reveal Geographic Heterogeneity in Genome Wide Linkage Study of Indian Visceral Leishmaniasis (2010) (34)
- Leishmaniasis: treatment, drug resistance and emerging therapies (2018) (33)
- High-throughput virtual screening and quantum mechanics approach to develop imipramine analogues as leads against trypanothione reductase of leishmania. (2016) (33)
- Imipramine Exploits Histone Deacetylase 11 To Increase the IL-12/IL-10 Ratio in Macrophages Infected with Antimony-Resistant Leishmania donovani and Clears Organ Parasites in Experimental Infection (2014) (33)
- Efficacy and Safety of Miltefosine in Treatment of Post-Kala-Azar Dermal Leishmaniasis (2015) (33)
- In Search of an Ideal Test for Diagnosis and Prognosis of Kala-azar (2010) (33)
- Adenosine deaminase activity in sera of patients with visceral leishmaniasis in India. (2008) (33)
- Significantly Lower Anti-Leishmania IgG Responses in Sudanese versus Indian Visceral Leishmaniasis (2014) (33)
- Diagnosis of kala-azar--an important stride. (2003) (32)
- Endocrine changes in male HIV patients. (2011) (32)
- Functionality of drug efflux pumps in antimonial resistant Leishmania donovani field isolates. (2009) (31)
- Induction of Th1-type cellular responses in cured/exposed Leishmania-infected patients and hamsters against polyproteins of soluble Leishmania donovani promastigotes ranging from 89.9 to 97.1 kDa. (2008) (31)
- Effectiveness and feasibility of active and passive case detection in the visceral leishmaniasis elimination initiative in India, Bangladesh, and Nepal. (2010) (31)
- Noninvasive Molecular Diagnosis of Human Visceral Leishmaniasis (2011) (31)
- Alteration of Fas and Fas ligand expression during human visceral leishmaniasis (2002) (31)
- Clinical and radiologic outcome of arthroscopic rotator cuff repair: single-row versus transosseous equivalent repair. (2016) (31)
- Cure of antimony-unresponsive Indian post-kala-azar dermal leishmaniasis with oral miltefosine. (2006) (31)
- Treatment of visceral leishmaniasis (2005) (30)
- Immune Checkpoint Targets for Host-Directed Therapy to Prevent and Treat Leishmaniasis (2017) (30)
- Research Priorities for Neglected Infectious Diseases in Latin America and the Caribbean Region (2010) (30)
- Post‐kala‐azar dermal leishmaniasis in visceral leishmaniasis‐endemic communities in Bihar, India (2012) (30)
- Sodium stibogluconate resistance in Leishmania donovani correlates with greater tolerance to macrophage antileishmanial responses and trivalent antimony therapy (2005) (30)
- Proteophosphoglycan is differentially expressed in sodium stibogluconate-sensitive and resistant Indian clinical isolates of Leishmania donovani (2007) (30)
- Management of visceral leishmaniasis: Indian perspective. (2005) (30)
- Recent advances in the diagnosis and treatment of kala-azar. (2012) (30)
- Determinants for progression from asymptomatic infection to symptomatic visceral leishmaniasis: A cohort study (2019) (30)
- Combined Immune Therapy for the Treatment of Visceral Leishmaniasis (2016) (29)
- In vitro and in vivo evaluation of anti-leishmanial and immunomodulatory activity of Neem leaf extract in Leishmania donovani infection. (2015) (29)
- Antibodies directed against O-acetylated sialoglycoconjugates accelerate complement activation in Leishmania donovani promastigotes. (2004) (29)
- No evidence for association between SLC11A1 and visceral leishmaniasis in India (2011) (29)
- Brief Definitive Report: Human visceral leishmaniasis is not associated with expansion or accumulation of Foxp3+ CD4 cells in blood or spleen (2010) (29)
- Kala-azar epidemic in Varanasi district, India (1999) (29)
- Diagnostic PCR with Leishmania donovani specificity using sequences from the variable region of kinetoplast minicircle DNA (1999) (29)
- Meta-taxonomic analysis of prokaryotic and eukaryotic gut flora in stool samples from visceral leishmaniasis cases and endemic controls in Bihar State India (2019) (28)
- Leishmania donovani Triose Phosphate Isomerase: A Potential Vaccine Target against Visceral Leishmaniasis (2012) (28)
- Understanding Human Leishmaniasis: The Need for an Integrated Approach (2006) (28)
- Identification of antibodies directed against O-acetylated sialic acids in visceral leishmaniasis: its diagnostic and prognostic role. (1998) (28)
- In vitro antileishmanial drug susceptibility of clinical isolates from patients with Indian visceral leishmaniasis--status of newly introduced drugs. (2012) (28)
- Voacamine alters Leishmania ultrastructure and kills parasite by poisoning unusual bi‐subunit topoisomerase IB (2017) (27)
- Amphotericin B colloidal dispersion for the treatment of Indian visceral leishmaniasis. (2006) (27)
- Immunoblot Analysis of the Humoral Immune Response to Leishmania donovani Polypeptides in Cases of Human Visceral Leishmaniasis: Its Usefulness in Prognosis (2002) (27)
- Evaluation of a diospyrin derivative as antileishmanial agent and potential modulator of ornithine decarboxylase of Leishmania donovani. (2013) (27)
- Simple Colorimetric Trypanothione Reductase-Based Assay for High-Throughput Screening of Drugs against Leishmania Intracellular Amastigotes (2013) (27)
- Over-Expression of 60s Ribosomal L23a Is Associated with Cellular Proliferation in SAG Resistant Clinical Isolates of Leishmania donovani (2013) (27)
- Population Preference of Net Texture prior to Bed Net Trial in Kala-Azar–Endemic Areas (2007) (27)
- Exposure to Phlebotomus argentipes (Diptera, Psychodidae, Phlebotominae) Sand Flies in Rural Areas of Bihar, India: The Role of Housing Conditions (2014) (26)
- Prevalence of human papillomavirus infection & cervical abnormalities in HIV-positive women in eastern India (2016) (26)
- Pharmacokinetics of oral sitamaquine taken with or without food and safety and efficacy for treatment of visceral leishmaniais: a randomized study in Bihar, India. (2011) (26)
- Reactive oxygen intermediates, nitrite and IFN‐γ in Indian visceral leishmaniasis (2001) (26)
- Efficacies of Vesicular and Free Sodium Stibogluconate Formulations against Clinical Isolates ofLeishmania donovani (2001) (26)
- Type I Interferons Suppress Anti-parasitic Immunity and Can Be Targeted to Improve Treatment of Visceral Leishmaniasis (2020) (26)
- Amplified fragment length polymorphism (AFLP) analysis is useful for distinguishing Leishmania species of visceral and cutaneous forms. (2010) (26)
- Validation of SYBR green I based closed tube loop mediated isothermal amplification (LAMP) assay and simplified direct-blood-lysis (DBL)-LAMP assay for diagnosis of visceral leishmaniasis (VL) (2018) (26)
- Identification of genetic markers in sodium antimony gluconate (SAG) sensitive and resistant Indian clinical isolates of Leishmania donovani through amplified fragment length polymorphism (AFLP). (2009) (25)
- Household cost‐of‐illness of visceral leishmaniasis in Bihar, India (2010) (25)
- Antimony-Resistant Leishmania donovani Exploits miR-466i To Deactivate Host MyD88 for Regulating IL-10/IL-12 Levels during Early Hours of Infection (2015) (25)
- Determinants of survival in adult HIV patients on antiretroviral therapy in Eastern Uttar Pradesh: A prospective study (2014) (25)
- Successful treatment of refractory visceral leishmaniasis in India using antimony plus interferon-gamma. (1994) (25)
- Genetic and functional evaluation of the role of CXCR1 and CXCR2 in susceptibility to visceral leishmaniasis in north-east India (2011) (25)
- A Correlative Study of Splenic Parasite Score and Peripheral Blood Parasite Load Estimation by Quantitative PCR in Visceral Leishmaniasis (2015) (25)
- Ketoconazole in visceral leishmaniasis (1990) (25)
- Leishmania donovani-Induced Increase in Macrophage Bcl-2 Favors Parasite Survival (2016) (24)
- Whole blood assay and visceral leishmaniasis: Challenges and promises. (2014) (24)
- Glycosylation of Erythrocyte Spectrin and Its Modification in Visceral Leishmaniasis (2011) (24)
- Th1 Stimulatory Proteins of Leishmania donovani: Comparative Cellular and Protective Responses of rTriose Phosphate Isomerase, rProtein Disulfide Isomerase and rElongation Factor-2 in Combination with rHSP70 against Visceral Leishmaniasis (2014) (24)
- Investments in Research and Surveillance Are Needed to Go Beyond Elimination and Stop Transmission of Leishmania in the Indian Subcontinent (2017) (24)
- Post kala-azar dermal leishmaniasis: A threat to elimination program (2020) (24)
- Understanding Leishmania parasites through proteomics and implications for the clinic (2018) (23)
- Ultrasonography for diagnosis of abdominal tuberculosis in HIV infected people. (2010) (23)
- Antileishmanial activity of cryptolepine analogues and apoptotic effects of 2,7-dibromocryptolepine against Leishmania donovani promastigotes (2012) (23)
- Nucleosomal Histone Proteins of L. donovani: A Combination of Recombinant H2A, H2B, H3 and H4 Proteins Were Highly Immunogenic and Offered Optimum Prophylactic Efficacy against Leishmania Challenge in Hamsters (2014) (23)
- Antimony Resistant Leishmania donovani but Not Sensitive Ones Drives Greater Frequency of Potent T-Regulatory Cells upon Interaction with Human PBMCs: Role of IL-10 and TGF-β in Early Immune Response (2014) (23)
- Visceral leishmaniasis: Spatiotemporal heterogeneity and drivers underlying the hotspots in Muzaffarpur, Bihar, India (2018) (23)
- Phenotypic and functional characteristics of HLA‐DR+ neutrophils in Brazilians with cutaneous leishmaniasis (2017) (22)
- Safety and efficacy of high-dose infusions of a preformed amphotericin B fat emulsion for treatment of Indian visceral leishmaniasis. (2009) (22)
- A novel recombinant Leishmania donovani p45, a partial coding region of methionine aminopeptidase, generates protective immunity by inducing a Th1 stimulatory response against experimental visceral leishmaniasis. (2012) (22)
- Development of an assay for quantification of linkage-specific O-acetylated sialoglycans on erythrocytes; its application in Indian visceral leishmaniasis. (2002) (22)
- Proteomic analyses of membrane enriched proteins of Leishmania donovani Indian clinical isolate by mass spectrometry. (2015) (22)
- A Subset of Neutrophils Expressing Markers of Antigen-Presenting Cells in Human Visceral Leishmaniasis. (2016) (22)
- Comparative proteomics and glycoproteomics of plasma proteins in Indian visceral leishmaniasis (2014) (22)
- Acute kidney injury-incidence, prognostic factors, and outcome of patients in an Intensive Care Unit in a tertiary center: A prospective observational study (2016) (22)
- Anti-66 kDa antileishmanial antibodies as specific immunodiagnostic probe for visceral leishmaniasis. (1994) (21)
- Molecular typing of HLA class I and class II antigens in Indian kala‐azar patients (1997) (21)
- Formulation, characterization and in vitro anti-leishmanial evaluation of amphotericin B loaded solid lipid nanoparticles coated with vitamin B12-stearic acid conjugate. (2020) (21)
- Serological tests for visceral leishmaniasis (2006) (21)
- Effect of treatment with interferon-gamma alone in visceral leishmaniasis. (1995) (21)
- The overexpression of genes of thiol metabolism contribute to drug resistance in clinical isolates of visceral leishmaniasis (kala azar) in India (2014) (21)
- Genetic and functional evaluation of the role of DLL1 in susceptibility to visceral leishmaniasis in India. (2012) (21)
- Genetic markers for SSG resistance in Leishmania donovani and SSG treatment failure in visceral leishmaniasis patients of the Indian subcontinent. (2012) (21)
- Safety of a pre‐formulated amphotericin B lipid emulsion for the treatment of Indian Kala‐azar (2008) (21)
- Wnt5a Signaling Promotes Host Defense against Leishmania donovani Infection (2017) (21)
- Purification, characterization of O-acetylated sialoglycoconjugates-specific IgM, and development of an enzyme-linked immunosorbent assay for diagnosis and follow-up of indian visceral leishmaniasis patients. (2004) (21)
- Amphotericin B lipid complex in the management of antimony unresponsive Indian visceral leishmaniasis. (1999) (20)
- A microculture technique for isolating live Leishmania parasites from peripheral blood of visceral leishmaniasis patients. (2007) (20)
- Arsenic, antimony, and Leishmania: has arsenic contamination of drinking water in India led to treatment- resistant kala-azar? (2015) (20)
- EVALUATION OF SALT-OUT METHOD FOR THE ISOLATION OF DNA FROM WHOLE BLOOD: A PATHOLOGICAL APPROACH OF DNA BASED DIAGNOSIS (2013) (20)
- Development and performance evaluation of amphotericin B transfersomes against resistant and sensitive clinical isolates of visceral leishmaniasis. (2010) (20)
- Determinants of bednet ownership and use in visceral leishmaniasis‐endemic areas of the Indian subcontinent (2010) (20)
- rK39 antigen for the diagnosis of visceral leishmaniasis by using human saliva. (2012) (19)
- Iron superoxide dismutase contributes to miltefosine resistance in Leishmania donovani (2019) (19)
- Proteomic approaches for discovery of new targets for vaccine and therapeutics against visceral leishmaniasis (2008) (19)
- Characterization and evaluation of amine-modified graphene amphotericin B for the treatment of visceral leishmaniasis: in vivo and in vitro studies (2014) (19)
- Detection and characterization of a sialoglycosylated bacterial ABC-type phosphate transporter protein from patients with visceral leishmaniasis (2009) (19)
- FAILURE OF KETOCONAZOLE TREATMENT IN CUTANEOUS LEISHMANIASIS (1995) (19)
- Genetic and functional evidence implicating DLL1 as the gene that influences susceptibility to visceral leishmaniasis at chromosome 6q27. (2011) (18)
- MOLECULAR CONFIRMATION OF THE PRESENCE OF COLIFORMS IN DRINKING WATER USING POLYMERASE CHAIN REACTION (2009) (18)
- Leptomonas seymouri narna-like virus 1 and not leishmaniaviruses detected in kala-azar samples from India (2017) (18)
- Possibility of membrane modification as a mechanism of antimony resistance in Leishmania donovani. (2007) (18)
- Inflammatory chemokines and their receptors in human visceral leishmaniasis: Gene expression profile in peripheral blood, splenic cellular sources and their impact on trafficking of inflammatory cells (2017) (18)
- The rK39 strip test is non-predictor of clinical status for kala-azar (2009) (18)
- Envisioning the innovations in nanomedicine to combat visceral leishmaniasis: for future theranostic application. (2019) (18)
- Xenodiagnosis to address key questions in visceral leishmaniasis control and elimination (2020) (18)
- Visceral Leishmaniasis IgG1 Rapid Monitoring of Cure vs. Relapse, and Potential for Diagnosis of Post Kala-Azar Dermal Leishmaniasis (2018) (18)
- Detection of Immunoglobulin G1 Against rK39 Improves Monitoring of Treatment Outcomes in Visceral Leishmaniasis (2018) (18)
- Residual activity and integrity of PermaNet® 2.0 after 24 months of household use in a community randomised trial of long lasting insecticidal nets against visceral leishmaniasis in India and Nepal. (2012) (18)
- Long-lasting Insecticidal Nets to Prevent Visceral Leishmaniasis in the Indian Subcontinent; Methodological Lessons Learned from a Cluster Randomised Controlled Trial (2015) (18)
- Male predominance in reported Visceral Leishmaniasis cases: Nature or nurture? A comparison of population-based with health facility-reported data (2020) (18)
- Diagnosis and treatment of Indian visceral leishmaniasis. (2003) (17)
- Degradation of pteridine reductase 1 (PTR1) enzyme during growth phase in the protozoan parasite Leishmania donovani. (2007) (17)
- Setting Our Sights on Infectious Diseases (2019) (17)
- MicroRNA exporter HuR clears the internalized pathogens by promoting pro‐inflammatory response in infected macrophages (2020) (17)
- Morphological and Genotypic Variations among the Species of the Subgenus Adlerius (Diptera: Psychodidae, Phlebotomus) in Iran (2014) (17)
- Reactive oxygen intermediates, nitrite and IFN-gamma in Indian visceral leishmaniasis. (2001) (17)
- Efficacy of Leishmania donovani trypanothione reductase, identified as a potent Th1 stimulatory protein, for its immunogenicity and prophylactic potential against experimental visceral leishmaniasis (2014) (17)
- Health & Demographic Surveillance System profile: the Muzaffarpur-TMRC Health and Demographic Surveillance System. (2014) (16)
- Genetic Heterogeneity in Clinical Isolates of Leishmania donovani from India (2011) (16)
- Enhanced expression of Toll‐like receptors 2 and 4, but not 9, in spleen tissue from patients with visceral leishmaniasis (2014) (16)
- Kala-azar epidemic in Varanasi district, (1999) (16)
- Alcoholic Fractions F5 and F6 from Withania somnifera Leaves Show a Potent Antileishmanial and Immunomodulatory Activities to Control Experimental Visceral Leishmaniasis (2017) (16)
- PCR-RFLP Based Method for Molecular Differentiation of Sand Fly Species Phlebotomus argentipes, Phlebotomus papatasi, and Sergentomyia babu Found in India (2012) (16)
- Identification of 9-O-acetylated sialoglycans on peripheral blood mononuclear cells in Indian Visceral Leishmaniasis (2004) (16)
- Evaluation of the status of tuberculosis as part of the clinical case definition of AIDS in India (2005) (16)
- Prevalence of sand flies and Leishmania donovani infection in a natural population of female Phlebotomus argentipes in Bihar State, India. (2012) (16)
- Transcriptome profiling identifies genes/pathways associated with experimental resistance to paromomycin in Leishmania donovani (2017) (16)
- Identification and characterization of a novel Leishmania donovani antigen for serodiagnosis of visceral leishmaniasis. (2012) (15)
- Characterization of the Proliferating Cell Nuclear Antigen of Leishmania donovani Clinical Isolates and Its Association with Antimony Resistance (2014) (15)
- Diagnostic and Prognostic Potential of a Competitive Enzyme-Linked Immunosorbent Assay for Leishmaniasis in India (1999) (15)
- Immunogenicity and Protective Efficacy of T-Cell Epitopes Derived From Potential Th1 Stimulatory Proteins of Leishmania (Leishmania) donovani (2019) (15)
- Establishing, Expanding, and Certifying a Closed Colony of Phlebotomus argentipes (Diptera: Psychodidae) for Xenodiagnostic Studies at the Kala Azar Medical Research Center, Muzaffarpur, Bihar, India (2017) (15)
- Effect of untreated bed nets on blood-fed Phlebotomus argentipes in kala-azar endemic foci in Nepal and India. (2009) (15)
- Epitope-Binding Characteristics for Risk versus Protective DRB1 Alleles for Visceral Leishmaniasis (2018) (14)
- Peripheral Blood Monocytes With an Antiinflammatory Phenotype Display Limited Phagocytosis and Oxidative Burst in Patients With Visceral Leishmaniasis (2018) (14)
- What steps can be taken to counter the increasing failure of miltefosine to treat visceral leishmaniasis? (2013) (14)
- Visceral leishmaniasis (2015) (14)
- Identification and Characterization of a Novel, 37-Kilodalton Leishmania donovani Antigen for Diagnosis of Indian Visceral Leishmaniasis (2011) (14)
- Transcriptional blood signatures for active and amphotericin B treated visceral leishmaniasis in India (2019) (14)
- Exploring the inhibitory activity of Withaferin-A against Pteridine reductase-1 of L. donovani (2016) (14)
- Mutations in an aquaglyceroporin as a proven marker of antimony clinical resistance in the parasite Leishmania donovani. (2020) (14)
- Immunostimulatory potential and proteome profiling of Leishmania donovani soluble exogenous antigens (2015) (13)
- Village health workers in Bihar, India: an untapped resource in the struggle against kala‐azar (2013) (13)
- Indian kala-azar--better tools needed for diagnosis and treatment. (2003) (13)
- Validity of existing CD4+ classification in north Indians, in predicting immune status. (2005) (13)
- Neurological Manifestations Hiv-Infected Patients Around Varanasi, India (2008) (12)
- Over-Expression of Cysteine Leucine Rich Protein Is Related to SAG Resistance in Clinical Isolates of Leishmania donovani (2015) (12)
- Comparative Analysis of Cellular Immune Responses in Treated Leishmania Patients and Hamsters against Recombinant Th1 Stimulatory Proteins of Leishmania donovani (2016) (12)
- TREATMENT OF VISCERAL LEISHMANIASIS : CURRENT STATUS (1997) (12)
- The molecular characterization of clinical isolates from Indian Kala-azar patients by MLEE and RAPD-PCR. (2005) (12)
- The Phenotype of Circulating Neutrophils during Visceral Leishmaniasis. (2017) (12)
- A molecular signature for CD8+ T cells from visceral leishmaniasis patients (2019) (12)
- Evaluation of rk39 immunochromatographic test with urine for diagnosis of visceral leishmaniasis. (2011) (12)
- Comparative Evaluation of Blood and Serum Samples in Rapid Immunochromatographic Tests for Visceral Leishmaniasis (2013) (12)
- Evaluation of Two Novel Rapid rKE16 Antigen-Based Tests for Diagnosis of Visceral Leishmaniasis in India (2012) (11)
- Nanonization increases the antileishmanial efficacy of amphotericin B: an ex vivo approach. (2014) (11)
- Development of a Multiplexed Assay for Detection of Leishmania donovani and Leishmania infantum Protein Biomarkers in Urine Samples of Patients with Visceral Leishmaniasis (2019) (11)
- Treatment of Post‐Kala‐Azar Dermal Leishmaniasis (1995) (11)
- Evaluation of Safety and Antileishmanial Efficacy of Amine Functionalized Carbon-Based Composite Nanoparticle Appended With Amphotericin B: An in vitro and Preclinical Study (2020) (11)
- Sero‐epidemiological study of kala‐azar in a village of Varanasi district, India (2006) (11)
- Efficacy and Safety of Paromomycin in Treatment of Post-Kala-Azar Dermal Leishmaniasis (2014) (11)
- Predictive markers of failure of first line anti retroviral treatment in HIV patients in India. (2013) (11)
- DYSTOCIA DUE TO ABNORMAL CALF IN A BUFFALO: A CASE REPORT (2010) (11)
- Novel Antigen Detection Assay to Monitor Therapeutic Efficacy of Visceral Leishmaniasis. (2016) (10)
- Human placental extract offers protection against experimental visceral leishmaniasis: a pilot study for a phase-I clinical trial (2008) (10)
- sMicro algal biodiesel synthesized from Monoraphidium sp., and Chlorella sorokiniana: Feasibility and emission parameter studies (2021) (10)
- Tumor necrosis factor alpha neutralization has no direct effect on parasite burden, but causes impaired IFN-γ production by spleen cells from human visceral leishmaniasis patients. (2016) (10)
- Lay perceptions of kala‐azar, mosquitoes and bed nets in Bihar, India (2010) (10)
- Visceral Leishmaniasis—Optimum Treatment Options in Children (2017) (10)
- Sexuality and social change: making the connection. Strategies for action and investment. (2005) (10)
- SWATH-MS based quantitative proteomics analysis to evaluate the antileishmanial effect of Commiphora wightii "Guggul" and Amphotericin B on a clinical isolate of Leishmania donovani. (2020) (10)
- Post-kala-azar dermal leishmaniasis (PKDL) in visceral leishmaniasis-endemic communities in Bihar, India. (2012) (10)
- Microsurgical management of aneurysms of the superior cerebellar artery - lessons learnt: An experience of 14 consecutive cases and review of the literature (2015) (10)
- Association of Interleukin-18 Gene Polymorphism with Susceptibility to Visceral Leishmaniasis in Endemic Area of Bihar, an Indian Population (2014) (10)
- Mass spectrometry-based proteomic analysis of Leishmania donovani soluble proteins in Indian clinical isolate. (2014) (9)
- Effectiveness of Single-Dose Liposomal Amphotericin B in Visceral Leishmaniasis in Bihar. (2019) (9)
- Nanodiagnostics in leishmaniasis: A new frontiers for early elimination. (2020) (9)
- Immunoprotective responses of T helper type 1 stimulatory protein‐S‐adenosyl‐L‐homocysteine hydrolase against experimental visceral leishmaniasis (2016) (9)
- Leishmania donovani evades Caspase 1 dependent host defense mechanism during infection. (2019) (9)
- Identification of a gene linked to drug resistance in field isolates of Leishmania donovani. (2002) (9)
- Recuperating Biopharmaceutical Aspects of Amphotericin B and Paromomycin Using a Chitosan Functionalized Nanocarrier via Oral Route for Enhanced Anti-leishmanial Activity (2020) (9)
- Echocardiographic evaluation of cardiac status in Indian visceral leishmaniasis patients. (2007) (9)
- Visceral Leishmaniasis in the Muzaffapur Demographic Surveillance Site: A Spatiotemporal Analysis (2018) (9)
- Atovaquone alone or with fluconazole as oral therapy for Indian kala-azar. (1998) (9)
- Gamma interferon in the treatment of Kala-azar and other forms of Leishmaniasis. (1995) (8)
- Retrospective Quarterly Cohort Monitoring for patients with Visceral Leishmaniasis in the Indian subcontinent: outcomes of a pilot project (2013) (8)
- Anaesthetic challenges in a patient with mitochondrial cytopathy undergoing surgery (2007) (8)
- Four layer multi-omics reveals molecular responses to aneuploidy in Leishmania (2021) (8)
- Improvising anti-leishmanial activity of Amphotericin B and Paromomycin using co-delivery in D-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) tailored Nano-lipid carrier system. (2020) (8)
- A novel 12.6-kDa protein of Leishmania donovani for the diagnosis of Indian visceral leishmaniasis. (2011) (8)
- Domestic Mammals as Reservoirs for Leishmania donovani on the Indian Subcontinent: Possibility and Consequences on Elimination. (2021) (8)
- More Efficient Ways of Assessing Treatments for Neglected Tropical Diseases Are Required: Innovative Study Designs, New Endpoints, and Markers of Effects (2012) (7)
- Recombinant Leishmania Rab6 (rLdRab6) is recognized by sera from visceral leishmaniasis patients. (2016) (7)
- Correction: Blimp-1-Dependent IL-10 Production by Tr1 Cells Regulates TNF-Mediated Tissue Pathology (2016) (7)
- Conservative management of liver abscess complicated by hepatogastric fistula. (2011) (7)
- A review of clinical trials of treatments for visceral leishmaniasis in the Indian subcontinent (India, Bangladesh and Nepal) (2010) (7)
- Leishmania donovani: Immunostimulatory Cellular Responses of Membrane and Soluble Protein Fractions of Splenic Amastigotes in Cured Patient and Hamsters (2012) (7)
- Therapeutic Leishmaniasis: Recent Advancement and Developments in Nanomedicines (2019) (7)
- Study the drug adherence and possible factor influencing drug adherence in HIV/AIDS patients in north eastern part of India (2014) (7)
- Human Papillomavirus Genome based Detection and Typing: A Holistic Molecular Approach. (2019) (7)
- Relationship between skin diseases and CD4 cell counts in a hospital-based cohort of HIV-infected adults in north India. (2008) (7)
- Identification of New Antigens in Visceral Leishmaniasis by Expression Cloning and Immunoblotting with Sera of Kala-Azar Patients from Bihar, India (2005) (7)
- Amphiregulin in cellular physiology, health, and disease: Potential use as a biomarker and therapeutic target (2021) (7)
- Analysis of Total Urine Proteins: Towards A Non-Invasive Approach for Diagnosis of Visceral Leishmaniasis. (2012) (6)
- Post kala azar dermal leishmaniasis and leprosy prevalence and distribution in the Muzaffarpur health and demographic surveillance site (2019) (6)
- Atypical mucocutaneous involvement with Leishmania donovani. (2012) (6)
- Platelet function studies in Indian kala-azar. (1995) (6)
- Monitoring drug effectiveness in kala‐azar in Bihar, India: cost and feasibility of periodic random surveys vs. a health service‐based reporting system (2011) (6)
- IL-10 and TGF-β Induced Arginase Expression Contributes to Deficient Nitric Oxide Response in Human Visceral Leishmaniasis (2021) (6)
- How do health care providers deal with kala-azar in the Indian subcontinent? (2011) (6)
- Clinical Abacavir Hypersensitivity Reaction among Children in India (2016) (6)
- A pilot study to evaluate the effect of HAART on gonadal dysfunction in male HIV patients (2015) (6)
- Governance and Standards in International Clinical Research: The Role of Transnational Consortia (2016) (6)
- Prophylactic Efficacy of High‐Molecular‐Weight Antigenic Fractions of a Recent Clinical Isolate of Leishmania donovani Against Visceral Leishmaniasis (2008) (6)
- A new scoring system for prediction of meniscal repair in traumatic meniscal tears (2019) (6)
- Interleukin 2 is an Upstream Regulator of CD4+ T Cells From Visceral Leishmaniasis Patients With Therapeutic Potential. (2019) (6)
- Why do Patients in Pre-Anti Retroviral Therapy (ART) Care Default: A Cross-Sectional Study (2016) (6)
- Ocular Manifestations and Human Immunodeficiency Virus Retinopathy in Patients with Acquired Immunodeficiency Syndrome in North India (2006) (6)
- IFN-γ+ CD4+T cell-driven prophylactic potential of recombinant LDBPK_252400 hypothetical protein of Leishmania donovani against visceral leishmaniasis. (2020) (5)
- Suppression of host PTEN gene expression for Leishmania donovani survival in Indian visceral leishmaniasis. (2016) (5)
- Leishmaniasis Laboratory Diagnosis of Visceral (2002) (5)
- Oral Miltefosine for Indian visceral leishmaniasis. N Engl J Med (2002) (5)
- Functional Involvement of Leishmania donovani Tryparedoxin Peroxidases during Infection and Drug Treatment (2017) (5)
- Immunological consequences of stress-related proteins – cytosolic tryparedoxin peroxidase and chaperonin TCP20 – identified in splenic amastigotes of Leishmania donovani as Th1 stimulatory, in experimental visceral leishmaniasis (2014) (5)
- Hepcidin mediated iron homoeostasis as immune regulator in visceral leishmaniasis patients (2018) (5)
- Clinical profile, risk factors and aetiology of young stroke: a tertiary care hospital based study from the Sub-Himalayan region in North India - (2014) (5)
- Understanding the transmission dynamics of Leishmania donovani to provide robust evidence for interventions to eliminate visceral leishmaniasis in Bihar, India (2016) (5)
- A rapid method to assess the stage differentiation in Leishmania donovani by flow cytometry. (2012) (5)
- Integrating genomics and proteomics permits identification of immunodominant antigens associated with drug resistance in human visceral leishmaniasis in India. (2017) (5)
- Short-Course Treatment With Imipramine Entrapped in Squalene Liposomes Results in Sterile Cure of Experimental Visceral Leishmaniasis Induced by Antimony Resistant Leishmania donovani With Increased Efficacy (2020) (5)
- Leishmania donovani Tryparedoxin Peroxidases: functional involvement during infection and drug treatment (2017) (5)
- Coalition of Biological Agent (Melatonin) With Chemotherapeutic Agent (Amphotericin B) for Combating Visceral Leishmaniasis via Oral Administration of Modified Solid Lipid Nanoparticles. (2021) (5)
- Carboxymethyl chitosan modified lipid nanoformulations as a highly efficacious and biocompatible oral anti-leishmanial drug carrier system. (2022) (5)
- Geographical Variability in Paromomycin Pharmacokinetics Does Not Explain Efficacy Differences between Eastern African and Indian Visceral Leishmaniasis Patients (2021) (5)
- Clinical profile and response to first-line ARV in HIV patients from Eastern UP and Bihar: a retrospective study. (2013) (5)
- Human papillomavirus infection & anal cytological abnormalities in HIV-positive men in eastern India (2018) (4)
- Identification and Functional Validation of a Biomarker for the Diagnosis of Miltefosine relapse during Visceral Leishmaniasis (2016) (4)
- An oral formulation of Amphotericin B for the treatment of visceral Leishmaniasis: f-Gr-AmB (2016) (4)
- Refining wet lab experiments with in silico searches: A rational quest for diagnostic peptides in visceral leishmaniasis (2019) (4)
- Vortex dynamics and second magnetization peak in the iron-pnictide superconductor Ca0.82La0.18Fe0.96Ni0.04As2 (2021) (4)
- Cloning, Expression and Purification of L. Donovani Specific Antigen for Serodiagnosis of Visceral Leishmaniasis (2013) (4)
- Evaluation of Blood agar micro-titer plates for culturing Leishmania parasites to titrate the parasite burden in spleen and peripheral blood of VL patients (2010) (4)
- Abnormal B-Cell Subset and Blimp-1-Mediated Humoral Responses Associated With Visceral Leishmaniasis Pathogenesis. (2019) (4)
- Molecular, biochemical characterization and assessment of immunogenic potential of cofactor-independent phosphoglycerate mutase against Leishmania donovani: a step towards exploring novel vaccine candidate (2017) (4)
- Combined neutralization of interferon gamma and tumor necrosis factor alpha induces IL-4 production but has no direct additive impact on parasite burden in splenic cultures of human visceral leishmaniasis (2018) (4)
- Interventions for visceral leishmaniasis (2017) (4)
- Assessing L. donovani Skin Parasite Load: A Proof of Concept Study of a Microbiopsy Device in an Indian Setting (2021) (4)
- Anti-Interleukin-10 Unleashes Transcriptional Response to Leishmanial Antigens in Visceral Leishmaniasis Patients. (2020) (4)
- Correction: Latent Infection with Leishmania donovani in Highly Endemic Villages in Bihar, India (2013) (4)
- Functionalization of Carbon Nanomaterials (e.g. Carbon Nanotubes and Graphene) Using L-Cysteine (2015) (4)
- Postoperative posterior ischemic optic neuropathy (PION) following right pterional meningioma surgery (2016) (3)
- HLA‐DR Class II expression on myeloid and lymphoid cells in relation to HLA‐DRB1 as a genetic risk factor for visceral leishmaniasis (2018) (3)
- Intramural hematoma of duodenum: An unusual complication after endoscopic therapy for a bleeding peptic ulcer (2011) (3)
- A Novel Bioimpedance-Based Detection of Miltefosine Susceptibility Among Clinical Leishmania donovani Isolates of the Indian Subcontinent Exhibiting Resistance to Multiple Drugs (2021) (3)
- Visceral leishmaniasis treatment in the Indian subcontinent: how to reach the most vulnerable (2012) (3)
- The drug resistance mechanisms in Leishmania donovani are independent of immunosuppression. (2020) (3)
- Particle induced X-ray emission study of blood samples of Indian Kala-azar patients (2017) (3)
- A Study on the Socio demographic Profile of the Attendees at the ICTC of Institute of Medical Sciences BHU, Varanasi, Uttar Pradesh (2016) (3)
- Challenges in the management of visceral leishmaniasis. (2005) (3)
- Factors affecting default among pre-ART patients in Eastern Uttar Pradesh (2012) (3)
- In Vivo Assessment of Antileishmanial Property of 4-(4,4,8-Trimethyl-7- oxo-3-oxabicyclo[3.3.1]non-2-yl)-benzoic Acid Methyl Ester, an Oxabicyclo[ 3.3.1]nonanones (2014) (3)
- The effect of TNF-α neutralization on parasite load and cytokine production in human visceral leishmaniasis (2016) (3)
- Metastatic medulloblastoma at diagnosis. (2011) (3)
- Leishmaniasis: Challenges in the Control and Eradication (2013) (3)
- MicroRNA mediated immune regulation of T helper cell differentiation and plasticity during visceral leishmaniasis infection: A computational approach (2016) (2)
- Sensible graphene oxide differentiates macrophages and Leishmania: a bio-nano interplay in attenuating intracellular parasite (2020) (2)
- Genetic and Functional Evidence Implicating DLL 1 as the Gene That Influences Susceptibility to Visceral Leishmaniasis at Chromosome 6 q 27 (2011) (2)
- Serial Quantitative PCR Assay for Detection, Species Discrimination, and Quantification of Leishmania spp. in Human Samples (cid:1) (2011) (2)
- Diagnosis of Visceral Leishmaniasis in an Elimination Setting: A Validation Study of the Diagnostic Algorithm in India (2022) (2)
- Dual malignancy: a rare presentation of synchronous periampullary carcinoma with renal cell carcinoma (2020) (2)
- Response to second line antiretroviral therapy in India (2012) (2)
- Tibial Plateau Slopes in Indian Patients with or without Anterior Cruciate Ligament Injury: A Magnetic Resonance Imaging Study (2016) (2)
- A Therapeutic Strategy for Treating Visceral Leishmaniasis in Regions with Drug Resistance (2011) (2)
- Isolation and characterisation of Leishmania donovani protein antigens from urine of visceral leishmaniasis patients (2020) (2)
- iagnosis of visceral leishmaniasis (2010) (2)
- Author response: Evolutionary genomics of epidemic visceral leishmaniasis in the Indian subcontinent (2016) (2)
- leishmaniasis in Bihar , India (2018) (2)
- Antibody response to sand fly saliva to evaluate human visceral leishmaniasis vector exposure in India and Nepal: effect of long-lasting insecticidal nets (2011) (2)
- HLA class II association with visceral leishmaniasis: The road to identifying vaccine candidates (2014) (2)
- Study of the profile of stroke in a tertiary-care hospital in the sub-Himalayan region in north India (2015) (2)
- Correction: Nucleosomal Histone Proteins of L. donovani: A Combination of Recombinant H2A, H2B, H3 and H4 Proteins Were Highly Immunogenic and Offered Optimum Prophylactic Efficacy against Leishmania Challenge in Hamsters (2021) (2)
- Study on pinocytosis by monocytes from visceral leishmaniasis patients (2002) (2)
- Utility of Blood as the Clinical Specimen for the Molecular Diagnosis of Post-Kala-Azar Dermal Leishmaniasis (2021) (2)
- A study to assess the etiology and clinical profile of patients with hyponatremia at a tertiary care hospital (2017) (1)
- Correction: Recombinant NAD-dependent SIR-2 Protein of Leishmania donovani: Immunobiochemical Characterization as a Potential Vaccine against Visceral Leishmaniasis (2015) (1)
- Mechanism of Drug Resistance in Visceral Leishmaniasis (2015) (1)
- False localizing oculomotor nerve palsy after endovascular coiling of a posterior communicating artery aneurysm (2018) (1)
- Febrifugine dihydrochloride as a new oral chemotherapeutic agent against visceral leishmaniasis infection. (2022) (1)
- COMPARATIVE STUDY OF Β-CYCLODEXTRIN PRODUCTION FROM THE CGTASE PRODUCING NOVEL STRAINS- ITS CHARACTERIZATION AND HOST-GUEST COMPLEX FORMATION (2014) (1)
- Comparative proteomics and glycoproteomics of plasma proteins in Indian visceral leishmaniasis (2014) (1)
- Investigating changes in monocyte phenotypes and functions in active visceral leishmaniasis patients (2016) (1)
- Combination liposomal amphotericin B (AmBisome (R), AmB) and miltefosine (MF) for the treatment of visceral leishmaniasis (VL) in northern Bihar, India (2007) (1)
- Multiple Relapses of Visceral Leishmaniasis after Combination Therapy in Immunocompetent Patient: Case Report (2016) (1)
- Increased amphiregulin expression by CD4+ T cells from individuals with asymptomatic Leishmania donovani infection (2022) (1)
- Proteomic screen implicates HSP 83 and a small kinetoplastid calpain-related protein in drug resistance in Leishmania donovani clinical field isolates by modulating drug-induced programmed cell death (2006) (1)
- Unilateral pulmonary edema--a report of two cases. (1992) (1)
- Arthroscopic assisted fixation of central depressed lateral tibial plateau fracture: case report (2020) (1)
- Herbal Medicines for Thyroid Diseases (2021) (1)
- EFFECTIVENESS OF SEPRAFILM AS ADHESION BARRIER FOLLOWING ABDOMINOPELVIC SURGERY- AN EXPERIMENTAL STUDY (2017) (1)
- Childhood Obesity to Type II Diabetes Mellitus- Pathogenesis, Importance of Behavioral Modifications and Limitations of Pharmacotherapy (2011) (1)
- Ethical research is grounded in quality data: a clinical data management workshop in Varanasi. (2013) (1)
- Meandering Pancreatic Duct as a Cause of Idiopathic Recurrent Pancreatitis (2018) (1)
- Management of visceral leishmaniasis: Indian Management of visceral leishmaniasis: Indian Management of visceral leishmaniasis: Indian Management of visceral leishmaniasis: Indian Management of visceral leishmaniasis: Indian (2005) (1)
- Exploiting knowledge on pharmacodynamics-pharmacokinetics for accelerated anti-leishmanial drug discovery/development (2019) (1)
- Role of B-cells and antibodies in visceral leishmaniasis infection (2016) (1)
- Immune Reconstitution Inflammatory Syndrome 533 91 Immune Reconstitution Inflammatory Syndrome (2007) (1)
- Studies on the arginase, 5′-nucleotidase and lysozyme activity by monocytes from visceral leishmaniasis patients (2012) (1)
- Current concepts review in the management of subscapularis tears. (2022) (1)
- Visceral leishmaniasis elimination in India: progress and the road ahead (2022) (1)
- P683 - Molecular typing of HLA class II DR antigens in indian kala azar patients (1996) (1)
- Livestock and rodents within an endemic focus of Visceral Leishmaniasis are not reservoir hosts for Leishmania donovani (2022) (1)
- Prevention of Antibiotic resistance / Antibiotic Misuse-Abuse (2009) (1)
- Spectrum Of Renal Disease In Visceral Leishmaniasis (2006) (1)
- Costs of Amphotericin B Lipid Complex for Kala-Azar (1998) (1)
- OUTCOME ANALYSIS OF PROXIMAL HUMERUS FRACTURES TREATED BY MINIMAL INTERNAL FIXATION (2014) (1)
- Prevalence of adherence, adverse effect and response of Anti Retroviral Therapy on People living with HIV in a programmatic setting-A Retrospective study (2016) (0)
- Workshop on Electrolyte and Acid-Base Disturbances (2009) (0)
- THE ADDED VALUE OF A MULTICOUNTRY NETWORK FOR PROMOTING ETHICAL AND REGULATORY STANDARDS IN CLINICAL TRIALS IN LOW- AND MIDDLE-INCOME COUNTRIES: THE EXPERIENCE OF THE ‘SWITCHING THE POLES NETWORK’ (2017) (0)
- Intensity Modulated Proton Beam Therapy (IMPT) in CNS and Skull Base Tumors: Prospective Data of 50 Patients With Early Clinical Follow-Up And Patient Reported Outcomes (2020) (0)
- InfectionClears Organ Parasites in Experimental Leishmania donovani Antimony-Resistant Macrophages Infected with To Increase the IL-12/IL-10 Ratio in Imipramine Exploits Histone Deacetylase 11 (2014) (0)
- Axillary Artery Injury in Closed Proximal Humerus Fracture. (2014) (0)
- Blood meal identification in wild-caught sand flies from the endemic region of visceral leishmaniasis in India (2018) (0)
- An Insight Into Systemic Immune Response in Leishmania donovani Mediated Atypical Cutaneous Leishmaniasis in the New Endemic State of Himachal Pradesh, India (2022) (0)
- Early Hours of Infection for Regulating IL-10 / IL-12 Levels during MyD 88 Exploits miR-466 i To Deactivate Host Leishmania donovani Antimony-Resistant and Syamal (2015) (0)
- Comparison of anti-Leishmania antibody responses in rKLO8- and rK39 ELISA using patient and control sera from three endemic regions. (2015) (0)
- Antileishmanial activity of cryptolepine analogues and apoptotic effects of 2,7-dibromocryptolepine against Leishmania donovani promastigotes (2012) (0)
- ASSESSMENT OF CHARACTERISTICS OF HIV CASES ASSOCIATED WITH PRESENTING WITH VERY POOR CLINICAL STAGE & CD4 COUNT (2018) (0)
- SLA-ELISA: A comparison with DAT & rK39 ELISA for identification of seroconverters (2016) (0)
- One arm included ACD through blanket screening of all households in villages in India and Bangladesh or focal screening of households in the neighborhood of an index (2010) (0)
- Identification of novel markers for the identification of visceral leishmaniasis (2014) (0)
- Hemorrhagic brain metastasis of an amelanotic melanoma foot: A case report (2012) (0)
- A Case Report on Migrated Kirschner Wires to Posterior Pharyngeal Wall (2014) (0)
- Validation of a simple resazurin-based promastigote assay for the routine monitoring of miltefosine susceptibility in clinical isolates of Leishmania donovani (2012) (0)
- 1094 CLINICAL BENEFITS OF EPOETIN BETA IN PATIENTS WITH ADVANCED STAGE HORMONE REFRACTORY PROSTATE CANCER (2011) (0)
- LB1.72 Prevalence of human papilloma virus infection and detection of hpv types in hiv- positive male patients followed by anal cytological abnormalities in eastern india (2017) (0)
- Molecular Diagnosis of Visceral Leishmaniasis (2018) (0)
- CLINICOPATHOLOGICAL PROFILE AND THERAPEUTIC APPRAISALS IN LYMPHOMA IN EASTERN UTTAR PRADESH (1997) (0)
- CHAPTER 64 Antileishmanial Resistance – Reasons and Remedies (2008) (0)
- Amine modified graphene mediated drug delivery of Amphotericin B for the treatment of visceral leishmaniasis (2014) (0)
- Safety and Effectiveness of Miltefosine in Post-Kala-Azar Dermal Leishmaniasis: An Observational Study (2023) (0)
- Running Title: Mechanism of Paromomycin resistance in L.donovani (2014) (0)
- Therapeutic Strategies in Kala-azar : Status 2011 (2011) (0)
- SWATH-MS based quantitative proteomics analysis to evaluate the antileishmanial effect of Commiphora wightii- Guggul and amphotericin B on a clinical isolate of Leishmania donovani. (2020) (0)
- 24 leishmaniasis-current BurDen anD trenDs (2012) (0)
- Challenges in the management of visceral leishmaniasis [editorial] (2005) (0)
- The overexpression of genes of thiol metabolism contribute to drug resistance in clinical isolates of visceral leishmaniasis (kala azar) in India (2014) (0)
- P028 CD4+ T cells are source of antigen specific interferon-gamma production in whole blood of patients with visceral leishmaniasis (2012) (0)
- Programming reproduction? Maternal health services. (1998) (0)
- Spider web appearance of loculated ascites on abdominal ultrasonography in the emergency department (2023) (0)
- Correction (2015) (0)
- Domestic Mammals as Reservoirs for Leishmania donovani on the Indian Subcontinent: Possibility and Consequences on Elimination (2020) (0)
- LeishmaniasisResponses in Human Visceral IL-27 and IL-21 Are Associated with T Cell (2013) (0)
- Nanomedicine with Reduced Drug Toxicity Capacity Against Leishmaniasis: Current and Future Prospects (2018) (0)
- Challenge Leishmania Protects Hamsters against-Infected Patients / Hamsters and Leishmania and IL-12 Response in Cured γ Strong IFN-, Generates Leishmania donovani Protein of Elongation Factor-2 , a Th 1 Stimulatory (2011) (0)
- Leishmaniasis IL-10 Responses in Human Visceral IL-27 and IL-21 Are Associated with T Cell (2011) (0)
- Chapter 12 Vaccine human clinical trial (2022) (0)
- The epidemiology of high-risk human papillomavirus infection and its correlation to cervical cytology among HIV-positive and HIV-negative women in Eastern India (2014) (0)
- THE PREVIOUS STUDIES OF OBSESSIVE COMPIULSIVE DISORDER 2.2. THE PREVIOUS STUDIES OF ANXIETY DISORDER 2.3. THE PREVIOUS STUDIES OF PHOBIA DISORDER 2.4. THEORETICAL ORITATION OF STUDY 2.4.1. THEORITICAL BACKGROUND OF OBSESSIVE COMPULSIVE DISORDER 2.4.2. THEORITICAL BACKGROUND OF ANXIETY DISORDER 2.4.3 (2015) (0)
- Metabolomic approach to study the Aerva sanguinolenta plant extract mechanism of action in Leishmania parasite (2018) (0)
- Antimony Resistance Clinical Isolates and Its Association with Nuclear Antigen of Leishmania donovani Characterization of the Proliferating Cell (2014) (0)
- A comparative evaluation of rapid immunochromatographic test for VL - whole blood vs serum (2014) (0)
- High-Throughput Screening of Drugs Reductase-Based Assay for Simple Colorimetric Trypanothione (2014) (0)
- SPONTANEOUS CHEST WALL HEMATOMA- AN UNCOMMON PRESENTATION OF CHRONIC MYELOID LEUKEMIA (2018) (0)
- Modulations in HLA-DR expression in visceral leishmaniasis infection (2016) (0)
- TREATMENT OF POST-KALA-AZAR DERMAL LEISHMANIASIS. AUTHOR'S REPLY (1995) (0)
- Diagnosis of Kala-Azar by Polymerase Chain Reaction (PCR) Technique (2014) (0)
- Drug Resistance in Leishmania: Clinical Perspectives (2009) (0)
- Transmission of Leishmania in the Indian Subcontinent (2019) (0)
- Diagnosis of kala-azar - an important stride [editorial] (1969) (0)
- Lymphocytes Typing by Flow Cytometry (2014) (0)
- Efficacy of Leishmania donovani trypanothione reductase, identified as a potent Th1 stimulatory protein, for its immunogenicity and prophylactic potential against experimental visceral leishmaniasis (2013) (0)
- Type I interferon signalling suppresses anti-parasitic CD4+ T cell responses during visceral leishmaniasis (2016) (0)
- A Molecular Signature for Il-10-Producing Th1 Cells in Protozoan Parasitic Diseases (2021) (0)
- Health seeking behavior of patients in Muzaffarpur-TMRC Health and Demographic Surveillance Site may obstruct Kala-azar elimination in Bihar, India (2018) (0)
- KEYWORDSPostoperative Adhesions, Seprafilm, Adhesion Barrier, Intraperitoneal Adhesions. (2017) (0)
- Blood monocytes are skewed towards non-inflammatory phenotype in patients with Human Visceral Leishmanisis (2018) (0)
- A Study on the Socio demographic Profile of the Attendees at the Integrated Counseling and Testing Centre of Institute of Medical Sciences BHU, Varanasi, Uttar Pradesh (2016) (0)
- Translation of open reading frame in kinetoplast DNA minicircles of clinical isolates of L. donovani (2007) (0)
- Proximal humerus fractures, minimal internal fixation, k-wires, osteosutures, osteoporosis, functional outcome. (2014) (0)
- Risk Factors associated with defaulting from visceral leishmaniasis treatment: analysis under routine programme conditions in Bihar, India (2017) (0)
- Immune response of humans to sand fly P. argentipes saliva: Western blot approach to identify novel salivary peptides with serum of asymptomatic infection in VL. (2013) (0)
- Hijacking the intrinsic vitamin B12 pathway for the oral delivery of nanoparticles, resulting in enhanced in vivo anti-leishmanial activity. (2022) (0)
- Optimal timing for initiation of antiretroviral therapy: a prospective study on treatment naive HIV patients (2012) (0)
- Impact of COVID-19 pandemic on vaccinations in children in a primary health centre in Northern India (2023) (0)
- Higher parasite burden In asymptomatic individuals In endemic areas of visceral leishmaniasis (2014) (0)
- Microplate whole blood interferon-γ release assay for marker of Leishmania donovani infection (2016) (0)
- An In-depth Proteomic Map of Leishmania donovani Isolate from Post Kala-azar Dermal Leishmaniasis (PKDL) Patient (2022) (0)
- Retraction notice to: Validity of existing CD 4+ classification in North Indians, in predicting immune status [J Infect 51 (2005) 41-46]. (2017) (0)
- What is the purpose of launching the World Journal of Clinical Infectious Diseases (2011) (0)
- Leptomonas seymouri narna-like virus 1 and not leishmaniaviruses detected in kala-azar samples from India (2017) (0)
- Innovative tools for assessing infectiousness in asymptomatic carriers in L. donovani: a proof of concept sudy of a novel microbiopsy device (2019) (0)
- Abstracts of the Eighth EDCTP Forum, 6–9 November 2016 (2017) (0)
- Symposium - Indian Kala-azar - Better Tools Needed for Diagnosis andTreatment (2003) (0)
- Risk factors for visceral leishmaniasis and Leishmania donovani infection in the Indian subcontinent (2014) (0)
- 653 POSITIVE RESPONSE TO BEVACIZUMAB WITH SELECTIVE BLADDER CONSERVATION IN RECURRENT AND METASTATIC BLADDER CANCER (2011) (0)
- A global comparative evaluation of commercially available rapid diagnostic tests for visceral leishmaniasis (2011) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With S. R. Shyam Sundar?
S. R. Shyam Sundar is affiliated with the following schools:
